Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
Open Access
- 1 November 2021
- Vol. 11 (11), e047878
- https://doi.org/10.1136/bmjopen-2020-047878
Abstract
Introduction Postembolisation syndrome (PES) is the most common side effect of vascular embolisation of solid organs. Although prophylactic corticosteroids are known to reduce the incidence and severity of PES, no trials investigating their efficacy have been conducted in men undergoing prostatic artery embolisation (PAE). We postulate that steroids can have a similar effect in reducing PES after PAE. This paper describes the rationale and detailed protocol for a randomised controlled trial evaluating the efficacy of dexamethasone (DEXA) in reducing PES after PAE. Methods and analysis In this single-centre, randomised, double-blind, placebo-controlled trial, we will enrol 60 individuals undergoing PAE for benign prostatic hyperplasia. Participants will be randomised to receive IV DEXA (24 mg) or placebo (saline). The primary outcomes will be postprocedural fever, pain and quality of life. The secondary outcomes will include postprocedural nausea, postprocedural medicine usage, laboratory parameters (C reactive protein, prostate-specific antigen) and early PAE results. Ethics and dissemination Ethics approval was obtained from the Danish Committee on Health Research Ethics in the Capital Region (H-20025910). The results from this trial will be disseminated through publication in peer-reviewed journals and national and international presentations. Trial registration number Clinicaltrials.gov identifier: NCT04588857; EudraCT number: 2020-000915-53.This publication has 25 references indexed in Scilit:
- Role of Corticosteroids during Cardiopulmonary BypassHospital Pharmacy, 2014
- Perioperative glucocorticoids in hip and knee surgery – benefit vs. harm? A review of randomized clinical trialsActa Anaesthesiologica Scandinavica, 2013
- Perioperative Single Dose Systemic Dexamethasone for Postoperative PainAnesthesiology, 2011
- Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstructionBJU International, 2011
- A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer painBMC Palliative Care, 2008
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Postembolization Syndrome: Changes in White Blood Cell Counts Immediately after Uterine Artery EmbolizationJournal of Vascular and Interventional Radiology, 2008
- Benign prostatic hyperplasiaThe Lancet, 2003
- Reduction of postembolization syndrome after ablation of renal angiomyolipomaAmerican Journal of Kidney Diseases, 2002
- Effect of methylprednisolone on the cytokine response in patients undergoing lung surgeryActa Anaesthesiologica Scandinavica, 1993